Abstract:Chlamydia vaccine approaches aspire to induce Th1 cells for optimal protection, despite the fact that there is no direct evidence demonstrating Th1-mediated Chlamydia clearance from the female reproductive tract (FRT). We recently reported that T-bet-deficient mice can resolve primary Chlamydia infection normally, undermining the potentially protective role of Th1 cells in Chlamydia immunity. Here, we show that T-bet-deficient mice develop robust Th17 responses and that mice deficient in Th17 cells exhibit delayed bacterial clearance, demonstrating that Chlamydia -specific Th17 cells represent an underappreciated protective population. Additionally, Th2-deficient mice competently clear cervicovaginal infection. Furthermore, we show that sensing of IFN-γ by non-hematopoietic cells is essential for Chlamydia immunity, yet bacterial clearance in the FRT does not require IFN-γ secretion by CD4 T cells. Despite the fact that Th1 cells are not necessary for Chlamydia clearance, protective immunity to Chlamydia is still dependent on MHC class-II-restricted CD4 T cells and IL-12p40. Together, these data point to IL-12p40-dependent CD4 effector maturation as essential for Chlamydia immunity, and Th17 cells to a lesser extent, yet neither Th1 nor Th2 cell development is critical. Future Chlamydia vaccination efforts will be more effective if they focus on induction of this protective CD4 T cell population. The mechanism that CD4 T cells use to mediate clearance of Chlamydia infection in the female reproductive tract remains unclear. Contrary to prevailing ideas, previous work from our lab demonstrated that the Th1 subset characterized by T-bet expression is not required for clearance. Here, we explore other T helper subsets and determine that Th2 cells are likewise not required while Th17 cells contribute to the early phase of infection clearance. Ultimately, the cytokine subunit IL-12p40 plays a substantial role in driving an effective CD4 T cell response that is not neatly defined by canonical CD4 subset Th1, Th2, or Th17 identity. Vaccine development thus should focus on this IL-12p40-driven CD4 T cell response rather than relying on markers of classical T helper subsets.

Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine

Immunity against a Chlamydia infection and disease may be determined by a balance of IL-17 signaling

Advances in Vaccine Development for Chlamydia trachomatis

Towards a Chlamydia trachomatis vaccine: how close are we?

Update on Chlamydia trachomatis Vaccinology

Elimination of Chlamydia muridarum from the female reproductive tract is IL-12p40 dependent, but independent of Th1 and Th2 cells

Interferon-Gamma Responses to Chlamydia trachomatis Vaccine Candidate Proteins in Chlamydia-Infected Women with Different Chlamydia Outcomes

Seventy Years of Chlamydia Vaccine Research – Limitations of the Past and Directions for the Future

Cytotoxic CD4+ T Cells Are Induced during Infection with Chlamydia trachomatis

Insights into innate immune cell evasion by Chlamydia trachomatis

Advances in Chlamydia trachomatis Vaccination: Unveiling the Potential of Major Outer Membrane Protein Derivative Constructs

Protective Anti-Chlamydial Vaccine Regimen-Induced CD4+ T cell Response Mediates Early Inhibition of Pathogenic CD8+ T cell Response Following Genital Challenge

The contribution of Chlamydia-specific CD8⁺ T cells to upper genital tract pathology

Irradiated whole cell Chlamydia vaccine confers significant protection in a murine genital tract challenge model

In silico design and analysis of a multiepitope vaccine against Chlamydia

Chlamydia trachomatis induces low-frequency, sustained CD4 T cell responses in most women, predominantly targeting chlamydial protease-like activity factor, CPAF

Structural Assessment of Chlamydia trachomatis Major Outer Membrane Protein (MOMP)-Derived Vaccine Antigens and Immunological Profiling in Mice with Different Genetic Backgrounds

Restriction & evasion: a review of IFNγ-mediated cell-autonomous defense pathways during genital Chlamydia infection

Antibody responses to Chlamydia trachomatis vaccine candidate antigens in Chlamydia-infected women and correlation with antibody-mediated phagocytosis of elementary bodies

Effect of Female Sex Hormones on the Immune Response against Chlamydia abortus and on Protection Conferred by an Inactivated Experimental Vaccine in a Mouse Model